Skip Navigation LinksHome > January 2011 - Volume 57 - Issue 1 > Pharmacological Activity of Novel 2-Hydroxyacetophenone Isat...
Journal of Cardiovascular Pharmacology:
doi: 10.1097/FJC.0b013e3181fd341c
Original Article

Pharmacological Activity of Novel 2-Hydroxyacetophenone Isatin Derivatives on Cardiac and Vascular Smooth Muscles in Rats

Gabriel, Daniele MSc*; Pontes, Luana Braga PhD*; da Silva, Jaqueline Soares MSc*; Sudo, Roberto Takashi MD, PhD*; Corrêa, Marilza Baptista PhD†; Pinto, Ângelo C PhD†; Garden, Simon John PhD†; Zapata-Sudo, Gisele MD, PhD†

Collapse Box


Isatin (1H-indole-2,3 dione) is an endogenous compound with biological activities. Many of its derivatives have pharmacological effects, including inhibition of cyclic guanosine monophosphate levels in cardiac tissue; sedative-hypnotic profiles; anticonvulsant, analgesic, antithermic, and anti-inflammatory activities; and anxiolytic, antimicrobial, and proapoptotic effects. Carbamates derived from isatin have a vasorelaxant profile. This study investigated the activity of 2 novel 2-hydroxyacetophenone derivatives of isatin (named MB101 and MB130) on the contractility of rat aorta and papillary muscles. Both compounds induced a concentration-dependent relaxation (5-100 μM) in the endothelium-intact aorta that was abolished by N-nitro-L-arginine methyl ester. Atropine, a muscarinic receptor antagonist, significantly prevented vasodilatation of 100 μM MB101. In contrast, atropine caused no significant alteration in MB130-induced vasorelaxation. Naloxone, a nonselective opioid receptor antagonist, completely prevented the relaxing effect of MB101 and MB130 at all concentrations. In papillary muscles, only MB130 induced a significant depression, and this contractile response was not altered by propranolol and atropine. Both the compounds reduced systolic and diastolic pressures in a dose-dependent manner in anesthetized rats. The 2-hydroxyacetophenones produced direct effects on vascular tonus through either muscarinic or opioid pathways. MB130 produced cardiac depression by opioid receptors and bradykinin because pretreatment HOE140 or with naloxone, an antagonist of type-2, bradykinin were able to partially block the decrease in twitch amplitude in papillary muscles induced by MB130. These findings provide information for designing new strategies for the treatment of cardiovascular disorders.

© 2011 Lippincott Williams & Wilkins, Inc.

Follow Us!


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.